Grants per year
Personal profile
Education/Academic qualification
Medicine, MD, Columbia College of Physicians and Surgeons
… → 2015
Fingerprint
Dive into the research topics where Yonatan Abraham Peleg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Active
-
Prot #ACT18064: A Parallel-Group Treatment, Phase 2a, Multicenter, Randomized, Double-Blind, PlaceboControlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, and Rilzabrutinib in Participants Aged 16 to 75 Years with Primary
Peleg, Y. A. (PD/PI)
ICON Clinical Research, LLC, Sanofi US Services Inc.
2/6/25 → 2/6/28
Project: Research project
-
Prot #KZR‑616‑202: A Phase 2b, Randomized, Controlled Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg with Placebo in Patients with Active Lupus Nephritis
Peleg, Y. A. (PD/PI) & Wadhwani, S. (PD/PI)
PPD Investigator Services, LLC, Kezar Life Sciences, Inc.
1/26/24 → 1/26/27
Project: Research project
-
Prot #APL2-C3G‐310: A Phase 3, Randomized, Placebo‐Controlled, Double‐Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune‐Complex Membranoproliferative Glomerulonephritis
Peleg, Y. A. (PD/PI)
Worldwide Clinical Trials, Inc., Apellis Pharmaceuticals, Inc.
9/25/23 → 9/25/26
Project: Research project
-
A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)
Peleg, Y. A. (PD/PI) & Wadhwani, S. (PD/PI)
12/1/21 → 6/13/25
Project: Research project
-
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
Cure Glomerulonephropathy (CureGN) Study Consortium, Jan 2024, In: American Journal of Kidney Diseases. 83, 1, p. 37-46 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation
Tarragón, B., Peleg, Y., Jagannathan, G., Sekulic, M., Chang, J. H., Cohen, D. J., Crew, R. J., Dube, G. K., Fernandez, H. E., Husain, S. A., Mohan, S., Morris, H. K., Appel, G. B., Jadav, P., Santoriello, D., Kudose, S., Stokes, M. B., Batal, I. & Bomback, A. S., Aug 2024, In: Clinical Journal of the American Society of Nephrology. 19, 8, p. 1005-1015 11 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation
Ahmad, S. B., Peleg, Y. & Ahn, W., Jan 1 2024, In: Current opinion in nephrology and hypertension. 33, 1, p. 61-66 6 p.Research output: Contribution to journal › Review article › peer-review
-
Liver Disease–Associated Glomerulopathies
Kanduri, S. R., Peleg, Y. & Wadhwani, S., Mar 2024, In: Advances in Kidney Disease and Health. 31, 2, p. 147-156 10 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations -
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies
Gauckler, P., Matyjek, A., Kapsia, S., Marinaki, S., Quintana, L. F., Diaz, M. M., King, C., Griffin, S., Ramachandran, R., Odler, B., Eller, K., Artan, A. S., Mirioglu, S., Busch, M., Schaepe, M., Turkmen, K., Cheung, C. K., Pepper, R. J., Juarez, G. F. & Pascual, J. & 29 others, , 2024, (Accepted/In press) In: Journal of the American Society of Nephrology. 10.1681/ASN.0000000520.Research output: Contribution to journal › Article › peer-review
3 Scopus citations